Riskpilot← Back to searchSign inGet full accessWEST PHARMACEUTICAL SERVICES DANMARK ApS
APSActiveCVR 16210714Fuglevangsvej 51Manufacture of light metal packaging · NACE 2592Est. 1999329 employees
Revenue 2024
DKK 1,1B
+5% vs 2023
EBITDA margin
9.0%
+15% vs 2023
Equity ratio
24.0%
Financial strength
Net profit 2024
DKK 11,7B
+15779% vs 2023
| Revenue | DKK 1,1B | +5% |
| EBITDA | DKK 101,8M | +15% |
| Net profit | DKK 11,7B | +15779% |
| Total assets | DKK 1,7B | -6% |
| Equity | DKK 398,1M | -63% |
| Employees | 329 | — |
Legal name
WEST PHARMACEUTICAL SERVICES DANMARK ApS
CVR number
16210714
Legal form
Anpartsselskab
NACE code
2592 · Manufacture of light metal packaging
Founded
16. oktober 1999
Share capital
DKK 50.000.000
Employees
329 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af bestyrelsens formand i forening med en direktør
Company purpose
Selskabets formål er at drive handel og produktion og anden i forbindelse hermed stående virksomhed
Address
Fuglevangsvej 51
Phone
+4575616000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 523.964 | 519.693 | 521.704 | 579.734 | 595.181 | 618.391 | 713.943 | 793.333 | 1.078.983 | 1.129.648 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 95.322 | 77.998 | 102.164 | 119.318 | 54.240 | 47.990 | 45.598 | 72.697 | 88.432 | 101.761 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 95.322 | 77.998 | 102.164 | 119.318 | 54.240 | 47.990 | 45.598 | 72.697 | 88.432 | 101.761 |
| Net financials | 202.507 | 294.272 | 333.499 | 312.148 | -9.904 | -10.689 | -10.454 | -13.737 | 7.841 | 11.676.304 |
| Profit before tax | 297.829 | 372.270 | 388.107 | 384.652 | 44.336 | 37.301 | 35.144 | 58.920 | 96.274 | 11.778.065 |
| Tax | 40.346 | 17.864 | 12.443 | 13.454 | 6.716 | 12.672 | 7.702 | 27.176 | 22.281 | 28.384 |
| Net profit | 257.483 | 354.406 | 375.664 | 371.198 | 37.620 | 24.629 | 27.442 | 31.744 | 73.993 | 11.749.681 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.052.358 | 2.387.767 | 2.764.508 | 1.116.503 | 1.566.411 | 1.580.646 | 1.666.296 | 1.946.531 | 1.774.963 | 1.661.458 |
| Equity | 1.713.994 | 2.079.505 | 2.052.591 | 404.037 | 835.383 | 860.012 | 887.454 | 994.198 | 1.068.191 | 398.147 |
| Long-term debt | 0 | 0 | 545.036 | 546.529 | 549.205 | 551.022 | 545.861 | 551.447 | 552.438 | 362.994 |
| Short-term debt | 331.508 | 300.375 | 157.673 | 154.050 | 167.749 | 154.612 | 219.416 | 389.442 | 142.855 | 888.730 |
| Total debt | 331.508 | 300.375 | 702.709 | 700.579 | 716.954 | 705.634 | 765.277 | 940.889 | 695.293 | 1.251.724 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20152024
Equity ratio
24.0%
This company
38.2%
Market median
-37% vs market
20152024
Return on equity
2951.1%
This company
18.4%
Market median
+15939% vs market
20152024
Net profit margin
1040.1%
This company
8.1%
Market median
+12741% vs market
20152024
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20152024
Debt / equity
3.17×
This company
0.62×
Market median
-411% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AK Deputy | Deputy | 2019 | — | — |
FK Management | Management | 1999 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2024 | |
West Pharmaceutical Services European Holdings ApS | Company | 100.0% | 100.0% | 2024 |
WEST PHARMACEUTICAL SERVICES HOLDING DANMARK ApS | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WEST PHARMACEUTICAL SERVICES DANMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Kronborg Jensen | Deputy | 0 companies |
| Finn Kämpf Hansen | Management | 0 companies |
| Peter Thorup Hovgaard | Board of Directors | 0 companies |
| Wai Wing Helen Chan | Board of Directors | 0 companies |
| Seamus Kilbane | Board of Directors | 0 companies |
| Kimberly Banks MacKay | Chairman | 0 companies |
| John Ditlev Larsen | Board of Directors | 0 companies |
| Shay Kearns | Chairman | 0 companies |
| Charlotte Monfeldt Horsbøll | Board of Directors | 0 companies |